Tyler B Jensen, PhD
About
Biography
Tyler is a seventh year MD/PhD student in the MSTP program and postdoctoral associate in the lab of Dr. Berna Sozen. He performed his PhD in the Genetics Department co-mentored by Dr. Siyuan Wang and Dr. Andrew Xiao (2020-2024). Tyler earned his bachelor’s degree in biochemistry from Northeastern University in 2017. During his undergraduate studies, he interned at Tetraphase Pharmaceuticals in 2014 working on tetracycline antibiotic development, and Epizyme Inc. in 2015, working on developing small molecule epigenetic inhibitors for molecularly defined cancers. In addition to his internships, Tyler worked in the lab of Dr. James Monaghan studying axolotls, working to understand the nervous system’s role in tissue regeneration. He is now studying chromatin biology during early embryonic development and helping build models of human embryogenesis. Tyler has been awarded the Ruth L. Kirschstein National Research Service Award (NRSA) F30 for his work on histone variants in human embryonic development through the National Institute of Child Health and Human Development (NICHD). His recent work has identified the critical role of the histone H2A variant H2A.J in human trophoblast and embryonic progression. By understanding how the earliest stem cells organize their genome during development, we can identify governing principles of cell fate determination, and how to better help patients with recurrent pregnancy loss.
Education & Training
- PhD
- Yale University, Genetics (2024)
- BS
- Northeastern University, Biochemistry (2017)
Research
Overview
Medical Subject Headings (MeSH)
ORCID
0000-0003-0220-4026
Research at a Glance
Yale Co-Authors
Publications Timeline
Anupama Hemalatha
Berna Sozen, PhD
Jenna Bergmann
Liangwen Zhong, PhD
Valentina Greco, PhD
Publications
2024
Selective utilization of glucose metabolism guides mammalian gastrulation
Cao D, Bergmann J, Zhong L, Hemalatha A, Dingare C, Jensen T, Cox A, Greco V, Steventon B, Sozen B. Selective utilization of glucose metabolism guides mammalian gastrulation. Nature 2024, 634: 919-928. PMID: 39415005, PMCID: PMC11499262, DOI: 10.1038/s41586-024-08044-1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCellular metabolismMammalian gastrulationHexosamine biosynthetic pathwayTranscription factor networksCellular signaling pathwaysSignaling morphogensGlucose metabolismCellular programmeBiosynthetic pathwayFate acquisitionCell fateHousekeeping natureGenetic mechanismsMesoderm migrationFactor networksERK activationExpression patternsSignaling pathwayDevelopmental processesStem cell modelCell typesSpecialized functionsDevelopmental contextMammalian embryosMouse embryos
2023
A genome-wide single-cell 3D genome atlas of lung cancer progression.
Liu M, Jin S, Agabiti SS, Jensen TB, Yang T, Radda JSD, Ruiz CF, Baldissera G, Muzumdar MD, Wang S. A genome-wide single-cell 3D genome atlas of lung cancer progression. BioRxiv 2023 PMID: 37546882, DOI: 10.1101/2023.07.23.550157.Peer-Reviewed Original ResearchHigh-content image-based CRISPR screening reveals regulators of 3D genome architectures
Yang B, Hu M, Jensen T, Radda J, Cheng Y, Jin S, Wang S. High-content image-based CRISPR screening reveals regulators of 3D genome architectures. Biophysical Journal 2023, 122: 306a. DOI: 10.1016/j.bpj.2022.11.1723.Peer-Reviewed Original ResearchCitations
2021
Lung injury in axolotl salamanders induces an organ‐wide proliferation response
Jensen TB, Giunta P, Schultz NG, Griffiths JM, Duerr TJ, Kyeremateng Y, Wong H, Adesina A, Monaghan JR. Lung injury in axolotl salamanders induces an organ‐wide proliferation response. Developmental Dynamics 2021, 250: 866-879. PMID: 33587313, DOI: 10.1002/dvdy.315.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLung regenerationLung massX cranial nervesLung injurySupplemental administrationCranial nervesProliferative responseProliferation responseInjury responseLungInjuryMultiple cell typesMesenchymal cellsNeuregulinAmputationMost tissuesPneumocytesProliferationCell typesResponseAxolotl salamanderCellsNerve
2020
Transcriptional Heterogeneity of Neural Stem Cells during Axolotl Salamander Spinal Cord Regeneration
Monaghan J, Jensen T, Stein D, Mun E, Maden M. Transcriptional Heterogeneity of Neural Stem Cells during Axolotl Salamander Spinal Cord Regeneration. The FASEB Journal 2020, 34: 1-1. DOI: 10.1096/fasebj.2020.34.s1.00360.Peer-Reviewed Original ResearchConceptsNeural stem cellsNascent RNA productionRepressive chromatin marksGlobal RNA synthesisProbe setsCell typesGlobal changeHippo-YAP signalingStem cellsStem cell dynamicsChromatin marksNascent RNATranscriptional outputWhole-mount tissuesTranscriptional heterogeneityAxolotl salamanderGlial cell typesGene transcriptionRNA productionFISH probe setsNeural progenitorsMultiplexed fluorescenceRegenerative programNeural differentiationNSC population
2017
Transcriptional correlates of proximal-distal identify and regeneration timing in axolotl limbs
Voss S, Murrugarra D, Jensen TB, Monaghan JR. Transcriptional correlates of proximal-distal identify and regeneration timing in axolotl limbs. Comparative Biochemistry And Physiology Part C Toxicology & Pharmacology 2017, 208: 53-63. PMID: 29107037, PMCID: PMC5920805, DOI: 10.1016/j.cbpc.2017.10.010.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAxolotl limbsDynamic transcriptional regulationSimilar transcriptional patternsCell cycle transcriptsDifferentiated muscle cellsProximal-distal limb axisExtracellular matrix moleculesMemory genesTranscriptional regulationTranscript abundanceTranscriptional patternsExpression patternsLimb regenerationGene expressionBlastema cellsPositional memoryArm cellsCell adhesionGenesMatrix moleculesCell surfaceEpithelial proteinsPositional informationTissue remodelingTranscriptional correlatesEpidermal Growth Factor Receptor Family Signaling in the Regenerating Axolotl Lung
Jensen T, Giunta P, Schultz N, Wong H, Monaghan J. Epidermal Growth Factor Receptor Family Signaling in the Regenerating Axolotl Lung. The FASEB Journal 2017, 31: 615.8-615.8. DOI: 10.1096/fasebj.31.1_supplement.615.8.Peer-Reviewed Original ResearchConceptsLung regenerationLung tissueLung injuryNeuregulin-1EGF family receptorsEpidermal growth factor receptor familyGrowth factor receptor familyFactor receptor familyDistal thirdErbB4 mRNALung cellsLungCompensatory mechanismsFamily receptorsHealth careReceptor familyGrowth factor signalingReceptor heterodimersInjuryEpidermal growth factor signalingTissueFactor signalingNovel mechanismErbB2Proliferation
2015
Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target
Waters NJ, Daigle SR, Rehlaender BN, Basavapathruni A, Campbell CT, Jensen TB, Truitt BF, Olhava EJ, Pollock RM, Stickland KA, Dovletoglou A. Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target. Journal Of Controlled Release 2015, 220: 758-765. PMID: 26385168, DOI: 10.1016/j.jconrel.2015.09.023.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdministration, OralAnimalsAntineoplastic AgentsBenzimidazolesBiological AvailabilityChemistry, PharmaceuticalDelayed-Action PreparationsDNA MethylationDogsDrug Administration ScheduleDrug CarriersEnzyme InhibitorsEpigenesis, GeneticGene Expression Regulation, LeukemicHistone-Lysine N-MethyltransferaseHumansInfusions, IntravenousInjections, SubcutaneousLeukemia, Biphenotypic, AcuteMaleMethyltransferasesMiceRats, Sprague-DawleyTumor BurdenXenograft Model Antitumor AssaysConceptsXenograft modelRefractory acute leukemia patientsFurther evaluationPhase 1 clinical trialSubcutaneous bolus administrationAcute leukemia patientsTumor growth inhibitionDOT1L inhibitor pinometostatExtended-release formulationRat xenograft modelMLL-r leukemiaThrice dailyPharmacodynamic markersSC administrationBolus administrationClinical trialsSubcutaneous administrationComplete bioavailabilityDOT1L activityLeukemia patientsOral administrationPatient conveniencePreclinical studiesSmall molecule inhibitorsImproved exposure